329 related articles for article (PubMed ID: 34638457)
1. Type 1 Nuclear Receptor Activity in Breast Cancer: Translating Preclinical Insights to the Clinic.
Kumar S; Freelander A; Lim E
Cancers (Basel); 2021 Oct; 13(19):. PubMed ID: 34638457
[TBL] [Abstract][Full Text] [Related]
2. Steroid hormone receptor gene expression in human breast cancer cells: inverse relationship between oestrogen and glucocorticoid receptor messenger RNA levels.
Hall RE; Lee CS; Alexander IE; Shine J; Clarke CL; Sutherland RL
Int J Cancer; 1990 Dec; 46(6):1081-7. PubMed ID: 2249895
[TBL] [Abstract][Full Text] [Related]
3. Anti-proliferative transcriptional effects of medroxyprogesterone acetate in estrogen receptor positive breast cancer cells are predominantly mediated by the progesterone receptor.
Moore NL; Hanson AR; Ebrahimie E; Hickey TE; Tilley WD
J Steroid Biochem Mol Biol; 2020 May; 199():105548. PubMed ID: 31805393
[TBL] [Abstract][Full Text] [Related]
4. Distribution, frequency, and quantitative analysis of estrogen, progesterone, androgen, and glucocorticoid receptors in human breast cancer.
Allegra JC; Lippman ME; Thompson EB; Simon R; Barlock A; Green L; Huff KK; Do HM; Aitken SC
Cancer Res; 1979 May; 39(5):1447-54. PubMed ID: 427788
[TBL] [Abstract][Full Text] [Related]
5. Interaction of nuclear receptors with the Wnt/beta-catenin/Tcf signaling axis: Wnt you like to know?
Mulholland DJ; Dedhar S; Coetzee GA; Nelson CC
Endocr Rev; 2005 Dec; 26(7):898-915. PubMed ID: 16126938
[TBL] [Abstract][Full Text] [Related]
6. Nuclear tristetraprolin acts as a corepressor of multiple steroid nuclear receptors in breast cancer cells.
Barrios-García T; Gómez-Romero V; Tecalco-Cruz Á; Valadéz-Graham V; León-Del-Río A
Mol Genet Metab Rep; 2016 Jun; 7():20-6. PubMed ID: 27114912
[TBL] [Abstract][Full Text] [Related]
7. FOXA1: A Pioneer of Nuclear Receptor Action in Breast Cancer.
Seachrist DD; Anstine LJ; Keri RA
Cancers (Basel); 2021 Oct; 13(20):. PubMed ID: 34680352
[TBL] [Abstract][Full Text] [Related]
8. Genome-wide crosstalk between steroid receptors in breast and prostate cancers.
Paakinaho V; Palvimo JJ
Endocr Relat Cancer; 2021 Jul; 28(9):R231-R250. PubMed ID: 34137734
[TBL] [Abstract][Full Text] [Related]
9. Hormone receptors in breast cancer: more than estrogen receptors.
Lamb CA; Vanzulli SI; Lanari C
Medicina (B Aires); 2019; 79(Spec 6/1):540-545. PubMed ID: 31864223
[TBL] [Abstract][Full Text] [Related]
10. Minireview: nuclear receptors and breast cancer.
Conzen SD
Mol Endocrinol; 2008 Oct; 22(10):2215-28. PubMed ID: 18417735
[TBL] [Abstract][Full Text] [Related]
11. Pushing estrogen receptor around in breast cancer.
Lim E; Tarulli G; Portman N; Hickey TE; Tilley WD; Palmieri C
Endocr Relat Cancer; 2016 Dec; 23(12):T227-T241. PubMed ID: 27729416
[TBL] [Abstract][Full Text] [Related]
12. Distinct nuclear receptor expression in stroma adjacent to breast tumors.
Knower KC; Chand AL; Eriksson N; Takagi K; Miki Y; Sasano H; Visvader JE; Lindeman GJ; Funder JW; Fuller PJ; Simpson ER; Tilley WD; Leedman PJ; Graham J; Muscat GE; Clarke CL; Clyne CD
Breast Cancer Res Treat; 2013 Nov; 142(1):211-23. PubMed ID: 24122391
[TBL] [Abstract][Full Text] [Related]
13. Steroid hormone receptors as targets for the therapy of breast and prostate cancer--recent advances, mechanisms of resistance, and new approaches.
Hoffmann J; Sommer A
J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):191-200. PubMed ID: 15860262
[TBL] [Abstract][Full Text] [Related]
14. Steroid Receptors in Breast Cancer: Understanding of Molecular Function as a Basis for Effective Therapy Development.
Kowalczyk W; Waliszczak G; Jach R; Dulińska-Litewka J
Cancers (Basel); 2021 Sep; 13(19):. PubMed ID: 34638264
[TBL] [Abstract][Full Text] [Related]
15. Increased androgen receptor expression in estrogen receptor-positive/progesterone receptor-negative breast cancer.
García X; Elía A; Galizzi L; May M; Spengler E; Martínez Vázquez P; Burruchaga J; Gass H; Lanari C; Lamb CA
Breast Cancer Res Treat; 2020 Feb; 180(1):257-263. PubMed ID: 31950383
[TBL] [Abstract][Full Text] [Related]
16. Targeting nuclear hormone receptors for the prevention of breast cancer.
Moyer CL; Brown PH
Front Med (Lausanne); 2023; 10():1200947. PubMed ID: 37583424
[TBL] [Abstract][Full Text] [Related]
17. Coordinated expression of oestrogen and androgen receptors in HER2-positive breast carcinomas: impact on proliferative activity.
Lin Fde M; Pincerato KM; Bacchi CE; Baracat EC; Carvalho FM
J Clin Pathol; 2012 Jan; 65(1):64-8. PubMed ID: 22039288
[TBL] [Abstract][Full Text] [Related]
18. Regulation of nuclear receptor and cofactor expression in breast cancer cell lines.
Vienonen A; Miettinen S; Manninen T; Altucci L; Wilhelm E; Ylikomi T
Eur J Endocrinol; 2003 Apr; 148(4):469-79. PubMed ID: 12656669
[TBL] [Abstract][Full Text] [Related]
19. The TSH/Thyroid Hormones Axis and Breast Cancer.
Voutsadakis IA
J Clin Med; 2022 Jan; 11(3):. PubMed ID: 35160139
[TBL] [Abstract][Full Text] [Related]
20. Post-translational modifications of nuclear receptors and human disease.
Anbalagan M; Huderson B; Murphy L; Rowan BG
Nucl Recept Signal; 2012; 10():e001. PubMed ID: 22438791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
